资讯

South Africa Today on MSN

The true burden of eczema goes beyond the itch

World Atopic Eczema Day 2025 calls for early intervention, better care, and greater awareness of the hidden toll of atopic ...
World Atopic Eczema Day 2025 highlights the lifelong impact of atopic eczema, a common inflammatory skin disease that often begins in infancy and can lead to food allergies, asthma, and other allergic ...
Anyone can have eczema, though CDC data shows that it’s disproportionately diagnosed in women. This complex condition is strongly linked to allergies, asthma, and other autoimmune issues. Common ...
The Cigna Group (NYSE: CI) is one of the best inexpensive stocks to buy according to hedge funds. On August 29, Phothera ...
Besides mosquito bites, other causes of itchy bumps on your skin may include hives, other bug bites like flea bites, and ...
Jefferies analysts expect a regulatory filing for rocatinlimab later this year, with a product launch in 2026.
Integrated Dermatology, the country's largest independent dermatology provider, proudly announces that Kiran Dhillon, MSN, APRN, FNP-C, has joined Integrated Dermatology of Yuma. A board-certified ...
Amgen (AMGN) stock in focus as the company and Kyowa Kirin (KYKOF) report Phase 3 data showing their atopic dermatitis drug, ...
As children return to school, common skin conditions that were previously under control may flare up once again, thanks to a ...
Sanofi (SNY) stock drops after Phase 3 trial results for amlitelimab, its experimental therapy for eczema, disappointed ...
Sanofi shares plunged at the market open Thursday as results from a late-stage trial of its experimental drug to treat skin conditions disappointed investors. Shares were 8.8% lower in early Paris ...